Hyperglycemic, high anion-gap metabolic acidosis in patients receiving SGLT-2 inhibitors for diabetes management
Keywords: Diabetic ketoacidosis; Sodium-glucose cotransporter-2 inhibitors; Insulinopenia; Hyperglycemia; C-peptide; Autoantibodies;